Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.
作者信息
Bilbao I, Parrilla P, Rimola A, Figueras J, Fabrega E, Gomez M, De Vicente E, Margarit C
机构信息
Unidad de Trasplante Hepatico, Hospital Vall d'Hebron, Barcelona, Spain.
出版信息
Transplant Proc. 1998 Aug;30(5):1833-7. doi: 10.1016/s0041-1345(98)00449-7.
PMID:9723300
Abstract
摘要
相似文献
1
Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.在296例肝移植患者中，将传统环孢素替换为新山地明环孢素后，口服环孢素剂量与环孢素血药浓度之间的相关性得到改善。
Transplant Proc. 1998 Aug;30(5):1833-7. doi: 10.1016/s0041-1345(98)00449-7.
2
Neoral-based immunosuppression in living-related donor liver transplantation.基于新山地明的免疫抑制在亲属活体供肝移植中的应用
Transplant Proc. 1998 Nov;30(7):3550-1. doi: 10.1016/s0041-1345(98)01131-2.
3
Conversion from Sandimmune to Neoral in stable liver graft recipients.
Transplant Proc. 1996 Aug;28(4):2244-6.
4
Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.稳定期肝移植患者从环孢素（山地明）转换为环孢素（新山地明）的安全性。
Transplant Proc. 1998 Aug;30(5):1852-3. doi: 10.1016/s0041-1345(98)00455-2.
5
Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.稳定期肝移植患者从传统环孢素制剂（山地明）转换为新型口服微乳剂（新山地明）的情况。
Transplant Proc. 1998 Aug;30(5):1857. doi: 10.1016/s0041-1345(98)00458-8.
6
Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
Transplant Proc. 1998 Aug;30(5):1658-9. doi: 10.1016/s0041-1345(98)00380-7.
7
Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.采用以新山地明为基础的双重免疫抑制方案后肝移植急性排斥反应减少。
Transplant Proc. 1998 Aug;30(5):1855-6. doi: 10.1016/s0041-1345(98)00457-6.
8
Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.小儿肝移植患者在转换为新山地明（Neoral）治疗后剂量需求增加及出现排斥反应。
Transplant Proc. 1998 Dec;30(8):4322-4. doi: 10.1016/s0041-1345(98)01426-2.
9
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
Transplant Proc. 1998 Jun;30(4):1401-2. doi: 10.1016/s0041-1345(98)00289-9.
10
Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.稳定的肾移植受者从传统的山地明转换为新山地明治疗。
Transplant Proc. 1996 Aug;28(4):2199-201.
Zotero 插件